DrugRisk Announces Pradaxa Alternative Approved by FDA

The DrugRisk Resource Center is the Web’s largest source for information on drug and medical device warnings, side effects and legal news. Visit http://www.DrugRisk.com Dallas, TX (PRWEB) January 04, 2013 The prescription drug resource center DrugRisk.com is alerting patients taking the blood thinner Pradaxa that the FDA recently approved Eliquis as another alternative to warfarin and Pradaxa for the prevention of strokes in patients with atrial fibrillation.* “The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations